Global Point of Care
Know your COVID-19 status in minutes with our reliable, fast results and the NAVICA™ App
Social distancing, hand washing, vaccines, and mask wearing are best practices for minimizing the spread of COVID-19. Testing is another powerful tool to help schools resume a more robust schedule and return to regular activities. Schools can verify students' testing status with the NAVICA System.
The BinaxNOW™ COVID-19 Ag Card and the NAVICA system can help your community get back to interacting with less interruption.
Download the NAVICA app, then take an Abbott rapid COVID-19 test at a NAVICA-enabled testing site or at home. The tests use a simple nasal swab and provide results in 15 minutes.
Receive a notification when test results are available to view in the NAVICA app. A negative test result automatically generates an encrypted NAVICA Pass. If the test is positive, the participant is advised to contact their healthcare provider, quarantine and follow CDC guidelines.
Display a NAVICA Pass, similar to an airline boarding pass, at NAVICA-enabled environments such as office buildings and schools to verify a recent negative test for COVID-19.
Download the NAVICA app, then take an Abbott rapid COVID-19 test at a NAVICA-enabled testing site or at home. The tests use a simple nasal swab and provide results in 15 minutes.
Receive a notification when test results are available to view in the NAVICA app. A negative test result automatically generates an encrypted NAVICA Pass. If the test is positive, the participant is advised to contact their healthcare provider, quarantine and follow CDC guidelines.
Display a NAVICA Pass, similar to an airline boarding pass, at NAVICA-enabled environments such as office buildings and schools to verify a recent negative test for COVID-19.
NAVICA will display a digital NAVICA Pass via a QR code, similar to an airline boarding pass, for the NAVICA user who has received a negative result from a NAVICA-enabled test site. This allows organizations to verify negative test results, enabling people to move about with greater confidence, or see a positive test result and request that the person self-quarantine to avoid infecting others.
Getting a NAVICA pass is an easy 3-step process:
The BinaxNOW COVID-19 Ag Card is a rapid lateral flow antigen test administered by a healthcare professional or a trained operator. It tests for active infection using a direct nasal swab. It provides a positive or negative result in 15 minutes with no instrument required.
Our technical services team can be reached Monday to Friday 8AM to 8PM Eastern Standard Time at (800) 257-9525. Please have the following information available so we can best assist you: phone type, phone operating version, and app version.
Google Play and the Google Play Logo are trademarks of Google LLC.
App Store and the Apple Logo are trademarks of Apple Inc.
The BinaxNOW™ COVID-19 Ag Card EUA has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization for use by authorized laboratories. The test has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
A Leader in Rapid Point-of-Care Diagnostics.
©2023 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement | Declaration for California Compliance Law.
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.
